Please try another search
For the six months ended 30 September 2021, Reno deMedici S.p.A. revenues increased 22% to EUR386M. Net incomebefore extraordinary items decreased 9% to EUR15.3M.Revenues reflect European Union segment increase of 19% toEUR208.9M, Rest of World segment increase of 65% toEUR73.4M. Net income was offset by Depreciation andamortization increase of 15% to EUR17.6M (expense),Financial expense increase of 68% to EUR2.3M (expense).
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 232.5 | 311.59 | 153.45 | 327.13 |
Gross Profit | 6.19 | 117.18 | 10.47 | 132.23 |
Operating Income | 0.78 | 2.61 | 5.48 | 13.93 |
Net Income | 12.09 | 3.42 | 4.87 | 8.63 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Assets | 726.78 | 497.48 | 523.73 | 515 |
Total Liabilities | 480.99 | 264.27 | 284.27 | 280.87 |
Total Equity | 245.78 | 233.22 | 239.46 | 234.13 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Period Length: | 0 Months | 6 Months | 0 Months | 0 Months |
Cash From Operating Activities | 13.22 | 72.7 | ||
Cash From Investing Activities | -2.9 | -21.77 | ||
Cash From Financing Activities | -15.49 | -28.23 | ||
Net Change in Cash | -5.12 | 22.6 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review